IgA nephropathy: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

  NCT05517980· Kira Pharmacenticals (US), LLC.· Source

• A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials

  2024-519638-22-00· Novartis Pharma AG· Source

• A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

  NCT05797610· Hoffmann-La Roche· Source

• Phase 2b Open-Label Repeat Kidney Biopsy Study

  NCT06740526· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· Takeda· Source

• A Study to Learn About the Effects of Felzartamab on the Kidneys of Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT07889362· Biogen· Source

• A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

  NCT07146906· Novartis Pharmaceuticals· Source

• Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  NCT07498335· Novartis Pharmaceuticals· Source

• Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)

  NCT07770815· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06935357· Biogen· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Mendelian Randomization Analysis 4
• Flow Cytometry 1
• Immunohistochemistry 1
• Cohort Studies 2
• Genome-Wide Association Study 2

See which targets of this disease your abstract mentions, and go to the people working on them.